Sriram Ganapathy is a highly accomplished scientist, specializing in immunology and cancer treatment. With a Bachelor of Engineering in Biotechnology and a PhD in Biochemistry and Cancer Biology from Rutgers University, he has extensive knowledge and skills to provide innovative solutions toward effective therapeutic procedures, accompanied by a deep understanding of the fundamental mechanisms of cancer progression and tumor cell recognition by the immune system.

As a postdoctoral fellow at Rutgers University and a Postdoctoral Researcher and Associate at the Massachusetts Institute of Technology (MIT), he has gained significant experience in academic research. Currently, as a Scientist of Immunology at Flagship Labs 65 Inc., he is committed to integrating chemo and targeted cancer therapeutics with immune stimulants to achieve durable anti-cancer responses.

Ganapathy is passionate about the development of better preventive strategies and effective therapeutic approaches for cancer patients, and he is always looking for opportunities to synergize his goals with those of his colleagues, corporations, and academic institutions.